Research graph
References from Integrating Viral Burden, Immune Dysregulation, and Tissue Injury for Predicting 28-Day Mortality in Severe Fever With Thrombocytopenia Syndrome: Development and External Validation of Interpretable Models. Local targets link to admitted publications; unresolved targets remain external evidence.
Fever with thrombocytopenia associated with a novel bunyavirus in China
10.1056/nejmoa1010095 · 2011 · External reference
Severe fever with thrombocytopenia syndrome, an emerging tick-borne zoonosis
10.1016/s1473-3099(14)70718-2 · 2014 · External reference
IL-6 and IL-10 Levels, Rather Than Viral Load and Neutralizing Antibody Titers, Determine the Fate of Patients With Severe Fever With Thrombocytopenia Syndrome Virus Infection in South Korea
10.3389/fimmu.2021.711847 · 2021 · External reference
Viral and Immunologic Factors Associated with Fatal Outcome of Patients with Severe Fever with Thrombocytopenia Syndrome in Korea
10.3390/v13122351 · 2021 · External reference
Immune Cells at the Frontline of SFTSV Infection
10.4014/jmb.2511.11002 · 2026 · External reference
CD8+T cells mediate antiviral response in severe fever with thrombocytopenia syndrome
10.1096/fj.202201343rr · 2023 · External reference
The clinical and immunological characteristics in fatal severe fever with thrombocytopenia syndrome virus (SFTSV) infection
10.1016/j.clim.2023.109262 · 2023 · External reference
Effect of Severe Fever With Thrombocytopenia Syndrome Virus Genotype on Disease Severity, Viral Load, and Cytokines in South Korea
10.1093/ofid/ofae508 · 2024 · External reference
Severe fever with thrombocytopenia syndrome phlebovirus non-structural protein activates TPL2 signalling pathway for viral immunopathogenesis
10.1038/s41564-018-0329-x · 2019 · External reference
CD4 T cell loss and Th2 and Th17 bias are associated with the severity of severe fever with thrombocytopenia syndrome (SFTS)
10.1016/j.clim.2018.07.009 · 2018 · External reference
Longitudinal analysis of immunocyte responses and inflammatory cytokine profiles in SFTSV-infected rhesus macaques
10.3389/fimmu.2023.1143796 · 2023 · External reference
Development and validation of a clinical and laboratory-based nomogram to predict mortality in patients with severe fever with thrombocytopenia syndrome
10.1186/s12879-024-10106-8 · 2024 · External reference
A model based on meta-analysis to evaluate poor prognosis of patients with severe fever with thrombocytopenia syndrome
10.3389/fmicb.2023.1307960 · 2024 · External reference
A machine learning model for mortality prediction in patients with severe fever with thrombocytopenia syndrome: a prospective, multicenter cohort study
10.1080/22221751.2025.2498572 · 2025 · External reference
Overview of the immunological mechanism underlying severe fever with thrombocytopenia syndrome (Review)
10.3892/ijmm.2022.5174 · 2022 · External reference
A nomogram to predict mortality in patients with severe fever with thrombocytopenia syndrome
10.1038/s41598-024-60923-9 · 2024 · External reference
The regulation of IL-10 production by immune cells
10.1038/nri2711 · 2010 · External reference
IL-10: the master regulator of immunity to infection
10.4049/jimmunol.180.9.5771 · 2008 · External reference
Antibodies against interleukin-10 receptor reduce IL-6 and TNF-α levels and increase TGF-β levels in patients with severe fever with thrombocytopenia syndrome virus and SARS-CoV-2 infection
10.3389/fimmu.2026.1828107 · 2026 · External reference
Serum interleukin-10 levels and mortality in severe fever with thrombocytopenia syndrome: a systematic review and meta-analysis
10.3389/fimmu.2026.1903694 · 2026 · External reference
Fatal outcome of severe fever with thrombocytopenia syndrome (SFTS) and severe and critical COVID-19 is associated with the hyperproduction of IL-10 and IL-6 and the low production of TGF-β
10.1002/jmv.28894 · 2023 · External reference
Deficient humoral responses and disrupted B-cell immunity are associated with fatal SFTSV infection
10.1038/s41467-018-05746-9 · 2018 · External reference
Antiviral immunity of severe fever with thrombocytopenia syndrome: current understanding and implications for clinical treatment
10.3389/fimmu.2024.1348836 · 2024 · External reference
Risk factor analysis and construction of risk nomogram for severe fever with thrombocytopenia syndrome based on clinical classification
2026 · External reference
Clinical laboratory parameters and fatality of Severe fever with thrombocytopenia syndrome patients: A systematic review and meta-analysis
10.1371/journal.pntd.0010489 · 2022 · External reference
Clinical features of severe fever with thrombocytopenia syndrome and analysis of risk factors for mortality
10.1186/s12879-021-06946-3 · 2021 · External reference
Severe fever with thrombocytopenia syndrome: a systematic review and meta-analysis of epidemiology, clinical signs, routine laboratory diagnosis, risk factors, and outcomes
10.1186/s12879-020-05303-0 · 2020 · External reference
Clinical progress and risk factors for death in severe fever with thrombocytopenia syndrome patients
10.1093/infdis/jis472 · 2012 · External reference
